MedTrace Logo

Pharmacokinetic of Thoracic Paravertebral Ropivacaine

NCT03721406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-02-16

No results posted yet for this study

Summary

The study aims to investigate the pharmacokinetic of ropivacaine in patients undergoing ultrasound guided thoracic paravertebral block (TPVB) both after a single-bolus injection via the thoracic paravertebral catheter given before the start of surgery and after continuous thoracic paravertebral infusion that will start after the end of the procedure in order to achieve postoperative analgesia after open thoracotomy during the first 3 postoperative days

Conditions

  • Open Thoracotomy

Interventions

DRUG

Ropivacaine

ropivacaine administerd via thoracic paraveretebral catheter

Sponsors & Collaborators

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Paraskevi K Matsota, Prof · 2nd Department of Anaesthesiology, "Attikon" University Hospital, Athens

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-08
Primary Completion
2021-10-25
Completion
2021-11-25

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03721406 on ClinicalTrials.gov